Due to Keap 1 (Kelch-like ECH-associated protein 1) sensitivity to electrophiles, mainly regulators of Nrf2, including exogenous antioxidants from plant-based food, interest has grown in understanding the role of Nrf2 as a therapeutic target for NAFLD [10]. The gene discussed is NFE2L2; the disease is metabolic dysfunction-associated steatotic liver disease.